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Abstract 
Werner syndrome is a syndrome which accelerates the normal aging process of an individual. The 
Syndrome is caused by mutations in the WRN gene. The precise link between this mutated gene and 
the phenotype is still unclear but much science has been done. By making this report I got an 
overview on what this link could be. Because of the multifunctional nature of the WRN protein, and 
the time limit of this project, it was impossible to get a full overview on all the cellular processes 
that WRN may be a part of but I focused on two important processes that is; DNA replication and 
telomere maintains. It is widespread accepted that WRN protein plays a role in this processes and 
lack of efficiency in this processes can cause the aging phenotype. By making this report I have 
discovered that WRN protein plays a role in many processes and can be considered as being a help-
protein. That is; lack of the WRN protein makes unstable processes. 
 
Dansk abstrakt 
Werner syndrome er et syndrom som accelererer den normale aldringsproces i et individ. 
Syndromet skyldes mutationer i WRN genet. Den præcises forbindelse mellem dette muterede gen 
og phenotypen er stadig usikker, men der er meget forskning på dette område. Ved at lave denne 
rapport fik jeg et overblik over, hvad denne forbindelse kunne være. På grund af WRN proteinets 
deltagelse i mange cellulære processer, og den begrænsede tidsperiode for projektet, var det umuligt 
at få det fulde overblik over alle de cellulære processer som WRN kan være en del af. Jeg 
fokuserede i stedet på to vigtige processer: DNA replikation og telomere vedligeholdelse. Det er en 
udbredt opfattelse, at WRN proteinet har en rolle i disse processer og en manglende effektivitet i 
disse processer kan frembringe denne ”ældnings”-phenotype. Ved at arbejde med denne rapport har 
jeg opdaget, at WRN proteinet har en rolle i mange processer og kan blive beskrevet som et 
hjælpeprotein. Dvs. mangel på WRN protein skaber ustabile processer. 
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Introduction 
In order to investigate the cellular processes causing aging it is very useful to find syndromes 
showing an accelerated aging process. By investigating the differences between individuals having 
these syndromes with individuals that do not suffer from these syndromes indications of the 
processes underlying aging can be found. The Werner syndrome is perfect in playing this indicator 
role. 
This syndrome accelerates a lot of the normal aging processes which can easily been seen in the 
phenotype of patients with this syndrome. The characteristic phenotype includes gray hair, 
cataracts, osteoporosis and diabetes. Other non-aging phenotype also occurs including short stature, 
soft tissue, calcification, and decreased fertility [Reviewed in Opresko et. al., 2003] 
That is: By studying this syndrome we also get an insight in the underlying cellular processes in 
non-Werner syndrome individuals. 
 
A lot of science still has to be done in order to find out functions underlying the Werner syndrome 
phenotype, but a big step was made when the gene, in which specific mutations cause the 
syndrome, was cloned in 1996. It was discovered that the Werner syndrome is caused mutations in 
the WRN gene. The next step is to explore how a mutated WRN gene can cause acceleration of 
aging processes and this is the main subject for this report. Because of lack of time, I will only 
investigate some hypothesis about WRN role in telomere maintenance and DNA replication 
although there are clearly indications that WRN playing a role in other processes for instance DNA 
repair.  
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The structure of the report 
The report has 2 theory sections followed by a section containing a discussion about what have been 
learned about WRN by making this report. That is: 
 
Main section Description 
Werner syndomre I start this section by giving a short clinical description of 
individuals with Werner, syndrome followed by a focus on the 
WRN gene and the product of this gene; the WRN protein. This 
will give the reader an introduction to the single gene and 
protein that, in a mutated state, is causing the phenotype related 
to Werner syndrome. 
WRN cellular process This section will present what cellular processes the WRN 
protein may be a part of. Many theories have been made about 
the function of WRN in many cellular processes. It is 
impossible to go into details with all functions so I will focus on 
two very important processes: Telomere maintenance and DNA 
replication. 
Discussion I will end the report with a discussion considering my view, 
based on this project, on the role of the WRN protein and the 
cause of the phenotype of Werner syndomre. 
 
 
Formulation: 
What problems in telomere maintenance and DNA replication processes, affected by a mutated 
WRN gene, is possibly causing Werner syndrome? 
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WRN gene and protein 
This part of the report will focus on the WRN gene and WRN protein (also named WS-protein) 
which, in mutated versions, can cause Werner syndrome. 
WRN gene and mutations causing Werner syndomre 
Werner syndrome is caused by mutations in the WRN gene. The gene position has been mapped to 
8p12 [Reviewed in Orren, 2006]. 
 
Many different mutations can cause a defect WRN gene and give rise to Werner syndrome. 
 
 
Figure 1 Various mutations on the WRN gene found in Werner syndrome patients. [University of Washington, 
2008] 
 
The NLS-part of the 3´-end of the gene encodes a nuclear localization sequence, that directs the 
protein into the cell nucleus (where DNA-replication etc. are taking place). All known Werner 
syndomre mutations are truncating mutations which results in premature translation of the protein. 
This has giving rise to the theory that because of truncations, no mutated WRN protein will ever 
enter the cell nucleus [Reviwed in Orren, 2006]. 
 
WRN plays a part in many cellular processes and a defect WRN gene has, as I will shows in this 
report, a negative influence on for instance the DNA repair systems, DNA replication and telomere 
maintains [Reviwed in Opresko et. al., 2003]. There are an increasing number of mutations in the 
DNA compared to individuals not having the symptom. This increasing number of mutations in the 
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genome is increasing the cancer risk for Werner syndomre-patients and this is also a common cause 
of death for individuals with the syndrome [Reviewed in Orren, 2006] 
 
Experiments also indicate that a mutated WRN gene cause has a dramatic effects on telomeres 
causing the length of telomeres to fluctuate over time and a experiment on Wener syndrome 
fibroblast cells shows that telomere in this cells showed a increase in erosion [Reviewed in Orren, 
2006]. It is very likely that telomere length is on major factor that affects longevity however this is 
still only a hypothesis [Kappei and Londonõ-Vallejo, 2007]. Werner syndrome is an autosomal 
recessive segmental progreoid syndrome [Reviewed in Orren, 2006]. Progeroid syndromes is a 
collective name for a rare genetic disorders which mimicking molecular and clinical features with 
respect to aging [Reviewed in Navarro et. al.,  2006]. 
Werner Protein (the gene product) 
The WRN gene is coding for the WRN-protein which is a protein of 1432 amino acids and a weight 
of 162 kilodaltons. The protein belongs to the RecQ-family of helicases. Members of this family are 
proteins which play a role in maintaining DNA largescale genomic stability [Reviewed in Orren, 
2006]. 
A lot of science is going on trying to figure out the specific processes WRN is implicated in 
however it is accepted that the WRN protein is playing a role in DNA metabolism [Reviewed in 
Orren, 2006]. 
More specific it is predicted that the protein plays a role in genomic stability via the processes DNA 
replication, DNA repair, DNA recombination and telomere metabolism. [Reviewed in Opresko et. 
al, 2003,] 
 
WRN belongs to the RecQ helicases protein family 
WRN is a member of the RecQ helicase family which is a sub-division of helicase enzymes. The 
proteins in the family are described in Figur 2. 
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Figur 2 WRN homologues in mouse Xenopus, yeasts, E. coli and human. Red boxes are helicase domains and 
blue boxes are exonuclease domains. [Martin and Oshima, 2000] 
 
In general RecQ proteins are considered as being the housekeeping helicase proteins that are 
required for maintenance of the genome. The WRN proteins also have a exonuclease domain in 
addition to their helicase domain [Reviewed in Hickson, 2003]. 
 
WRN proteins domains 
The WRN protein contains 4 protein domains and 2 signal peptides as shown in Figure 3. 
 
Figure 3 Domains of the WRN protein [Brosh et al., 2001] 
 
This shows that the protein consists of 4 structural domains (exonuclease, helicase, REQ and 
HRDC domain) two of which have described enzymatic activities, e.g. the exonuclease and 
helicase/ATPase domain. 
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The overall functions of each of the domains are: 
Domain Function Structure 
Exonuclease WRN has an exonuclease domain degrading DNA 
in the 3´-5´-direction.. This domain preferentially 
removes mismatched nucleotides from the 3´-
terminal end and initiates DNA degradation at a 
duplex blunt end in cases of DNA junction or 
alternate structure occurring in DNA. 
[Reviewed in Opresko et. al., 2003] 
From "Revealing the 
Secrets of WRN" by 
Research News, 2006 
 
ATPase/Heli
case 
Helicase unwinds DNA duplexes. 
Like other protein of the RecQ-family this domain 
takes part in DNA replication, DNA recombination 
and DNA repair. 
[Reviewed in Brosh et. al. , 2006]. 
 
ATPase means that the energy used in the function 
is coming from ATP which is converted into ADP. 
The free energy chance in these reactions gives 
energy to the helicase. 
 
The prerered helicase target is (in the right order): 
1. Non-B form DNA G-quadruplexes and triple 
helix. 
2. D-Loops, Holliday junctions and three-way 
junctions. 
3. Bubbles, forks and flaps. 
[Reviewed in Cheng et. al., 2007] 
The crystal 
structure of this 
domain has not 
been resolved. 
 
RQC The RQC is playing a role in protein to protein 
interactions. Rescent studies indicates that the 
The crystal 
structure of this 
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domain is multi functional and that it stimulates 
FEN-1 incision and signaldependent nuclear 
localization [Reviewed in von Kobbe et. al. 2003]. 
RQC is a structure specific DNA binding domain. 
[von Kobbe et. al. 2003] 
domain has not 
been resolved. 
 
HRDC One experiment showed that residues 1152–1226 
fold into a conventiel HRDC domain.of five -
helicses (as show in the picture). 
Some of the hydrophobic residues make a domain 
core that is important in hydrophobic interactions 
[Kitano, 2007]. 
P53 (tumor repressor), RAD52 and p50 subunit of 
DNA polymerase  indicates to bind to the HRDC-
domain of WRN. The authors could no find an 
indication of a DNA-binding site in vitro [reviewed 
in Kitano, 2007]. 
 
 
From "Human DNA 
Helicase WRN 
(RecQL2)" from 
Davidson College. 
 
NLS 
(Actually not 
a domain but 
just a amino-
sequence) 
The NLS signal sequence in the C-terminal end 
directs the newly synthesized protein to be 
transported into the nucleus. [Reviewed in Opresko 
et. al., 2003] and is locazation is residues 1370-
1375 [reviwed in von Kobbe and Bohr, 2002]. 
Like other eukaryote proteins with a NLS-sequence 
the protein is targetted by cytoplasmic receptor 
proteins and transported into the nucleus through 
the nuclear pores-complex.[Griffiths et. al. 2008] 
 
NTS 
(Actually not 
a domain but 
just a amino-
sequence) 
A nucleular targeting sequence within residues 949-
1092 that tagets WRN to nucleoli foci inside the 
nucleaus [von Kobbe and Bohr, 2002]. Experiment 
made by Kobbe and Bohr has shown that WRN 
lacking residues 853-1089 showed a complete 
nucleolar exclusion pattern [von Kobbe and Bohr, 
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2002]. 
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The role of WRN in cellular processes in DNA replication and 
telomere maintains 
This part of the report contains information about what cellular processes that WRN may be a part 
of. 
DNA replication 
This part of the report will focus on the DNA-replication involved proteins that WRN interacts 
with. Werner syndrome cells show an extended division cycle, probably because of an extended s-
phase, and a slower rate of DNA-replication. This is consistent with the fact that WRN interact with 
a many replications proteins including DNA polymerase , PCNA, RPA, FEN-1 [reviewed in 
Orren, 2006] and Toposomerase I [Reviewed in Ozgenc and Loeb, 2005]. 
In this section I will describe experiments showing the binding between WRN and the proteins 
mentioned above. 
I have chosen not to a give full description on how these interactions and functions for every protein 
have been indicated but I will give a detailed description on how it was determined been done in the 
case of WRN-FEN-1 binding. For the other proteins I will just give an example on one relevant 
experiment indicating the protein-protein interaction.  
 
WRN protein interacts with DNA replication proteins 
WRN has been found to interact with RPA1 and other enzymes playing an important role in DNA 
replication [Reviwed in Opresko et. al., 2003]. 
FEN-1 is a 5’-flap endonuclease/5’-3’ exonuclease involved in maturation of Okazaki 
fragments.during DNA replication, long patch base excision repair (BER) and non-homologeus 
DNA end joining (NHEJ) [Reviewed in Ozgenc and Loeb., 2005] also seems to be processes that 
WRN takes part in. 
 
• FEN-1 
Interaction of WRN with FEN-1 stimulates a more than 80-fold increase in nucleolytic activity of 
FEN-1.  [Reviewed in Ozgenc and Loeb, 2005]. 
                                                 
 
RPA or Replication Protein A (RPA) is a DNA single stranded binding protein required for DNA replication and 
nucleotide exicision repair [Abramova et al., 1997] 
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The physical interaction between FEN-1 and WRN has been demonstrated in an in vitro GST-
pulldown assay [Brosh et. al., 2001] GST-WRN proteins were mixed with nuclear extracts and then 
the GST-WRN proteins were bound to GST-beads. If any protein from the nuclear extract binds to 
WRN they will also indirectly bind to the beads. That is: 
 
Figure 4 Possible binding in the experiment 
Binding between GST-marked WRN-fragments and FEN-1 have been shown as a band in the gel 
recognized by FEN-1 antibody where it was also shown that this binding is between the WRN C-
terminal and FEN-1 as shown in Figure 5. 
 
Figure 5 Pulldown GST assay testing binding of GST-WRN and FEN-1 from nuclear extract [Brosh et. al., 2001] 
 
Lane Substrates 
1 Human nuclear extract (with FEN-1) 
2 GST beads+human nuclear extract (containing FEN-1) 
3 GST-WRN949-1432 beads (C-terminal) +human nuclear extract (containing FEN-1) 
4 GST+WRN1072-1236 beads (not C-terminal) +human nuclear extract (containing FEN-1) 
5 GST+WRN949-1432 beads (C-terminal) 
6 GST+WRN1072-1236 beads (not C-terminal) 
 
Lane 1 is a control showing that the nuclear extract contains FEN-1. 
As shown only lane 3 indicates that FEN-1 is present in the pull down beads. As shown in the table 
this pulldown has been done using GST-WRN949-1432 beads It can seen that the last part of the 
WRN949-1432  protein binds to FEN-1 found in the nuclear extract. Lane 2, 4, 5 indicates no FEN-1 
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although the FEN-1 antibody shows sign of some kind of binding to other proteins which, 
according to the authors, is cross-reactivity of FEN-1 antibody to bacterial proteins. 
 
To check if FEN-1 still binds to the WRN949-1432 protein in a nuclear extract abscent environment 
another GST-pull down experiment was done but this time only pure FEN-1 and WRN949-1432  was 
used as substrates. 
The result is shown in Figure 6: 
 
Lane Subtrate 
1 Beads with GST 
2 GST+WRN949-1432 beads + FEN-
1 
3 GST+WRN949-1432 beads 
4 GST+WRN949-1432 beads + FEN-
1 (20 ng) 
 
 
Figure 6 Pulldown GST assay testing binding of WRN and pure FEN-1[Brosh et. al. , 2001] 
This experiment clearly indicates the interaction between the C-terminal of the WRN protein 
(GST+WRN949-1432) and FEN-1. That is; there is a direct binding between WRN and FEN-1 [Brosh 
et. al. , 2001]. 
To be sure that full length WRN protein interacts with FEN-1 a new experiment was done. The 
pulldowns were done with full length WRN and FEN-1-Sapharose beads (GST). That is; the 
possible binding between FEN-1 and WRN could be: 
 
Figure 7 Possible binding between FEN-1 Sepharose beads and full length WRN 
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BSA-Sepharos beads was made as well to test that WRN could not bind to Sepharose beads alone. 
WRN from the immunoprecipitate was 
detected with WRN antibody. 
The result is shown in Figure 8. 
 
 
 
 
 
 
 
The result shows that there is a weak binding between WRN and BSA-Sepharose (lane 3) although 
this binding should not be present because BSA should not bind to WRN. However there is a strong 
binding between WRN and FEN-1 Sepharos beads (lane 4). Therefore there is a clear indication of 
an interaction between full length WRN and FEN-1. 
 
The authors tested this binding in vivo. 
A co-immunoprecipitation experiment was made were WRN antibody was bond to protein agarose. 
It was tested if this WRN antibody/protein agarose complex binds indirectly to FEN-1. That is; the 
possible binding would be: 
 
Figure 9 Possible binding between Protein agarose-WRN antibody, WRN and FEN-1 
The experiment was done in extracts from HeLa whole-cells. 
The result is shown in  
 
 
 
 
Figure 10. 
 
Lane Subtrate 
1 Result after 3 washes of a 
WRN+ BSA-Sepharose 
2 Result after 3 washes of a 
WRN+ FEN-1 Sepharose 
beads. 
3 Subtrate of WRN and 
BSA-Sepharose 
4 Subtrate of WRN and 
FEN-1 Sepharose beads. Figure 8 Interaction between 
full length WRN and FEN-1-
Sapharose. The broad band 
indicates a WRN protein 
[Brosh et. al., 2001]. 
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Figure 10 In vivo binding between FEN-1 and WRN [Brosh et. al., 2001] 
 
 
 
 
 
 
 
 
 
 
In lane 3 show from immunoprecipiation with WRN antibody/protein agarose was tested and FEN-
1 antibody and WRN antibody showed that both FEN-1 and WRN was present in this precipitate. 
It is worth noticing that that when the same immunoprecipation was done on Werner syndrome 
(lane 6) no WRN and no FEN-1 could be found. This clearly indicates that cells there is no binding 
between Werner syndrome WRN-protein and FEN-1. 
Conclusion: The conclusion of these 4 experiments is that WRN interact directly with FEN-1. The 
interaction is between the last part of the protein and FEN-1 and this is also the case in vivo. 
 
Lane Substrate 
1 HeLa cell lysate with immunoprecipiation without anti-WRN. 
2 HeLa cell lysate. 
3 Immunoprecipiation with WRN antibody/protein agarose on extracts from 
HeLa cells. 
4 Lysate from Werner syndrome HeLa cells. 
5 Immunoprecipiation with WRN antibody/protein agarose on extracts from 
Werner syndrome cells. 
6 Pure FEN-1. 
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• RPA (Replication Protein A) 
RPA enables WRN to unwind partial duplexes with a length of at lest 1000 bps (the longest 
fragment tested). Normally WRN can only unwind fragments with no more than 40 bps [Reviewed 
in Ozgenc and Loeb., 2005]. 
RPA and WRN also work together in case of a replication fork arrest caused by hydroxyurea once 
again indicating that there is a strong connection between restarting replication fork and WRN 
function [Reviewed in Opresko et. al. , 2003] 
 
In an experiment with induced stalled replication forks this interaction has been detected. HeLa 
cells were treated with hydroxurea (causing lack of dNTP and inducing replication arrest) and by 
use of anti-WRN and anti-RPA antibodies it was clearly shown that inhibition of replication 
induced WRN protein transport to distinct nuclear foci where RPA is present.The experiment is 
illustrated in Figure 11. 
 
Figure 11 Localization of RPA (A) and WRN (B) in case of an arrested S-phase. Picture D shows the normal 
localization of WRN. C is an overlay of picture A and B showing co-localization of WRN and RPA upon 
treatment with hydroxurea. See table on next page for details. [Constantinou et. al, 2000] 
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Pictue Shows 
A HeLa cell in an arrested s-phase. Localization of WRN protein 
B HeLa cell in an arrested s-phase. Localization of RPA protein 
C HeLa cell in an arrested s-phase. Localizations of both RPA and WRN 
protein (superimposed picture) 
D Normal localization of WRN proteins in HeLa a cell. 
 
• DNA polymerase  
Experiments also indicate that WRN both physically and functionally interacts with DNA 
polymerase  by binding to the p50 subunit of the polymerase. Addition of WRN protein induces 
translocation of the p50-subunit to the nucleolus which indicates that WRN protein can control the 
activity level of polymerase . In another experiment it has also been shown that WRN can speed 
up the processinity of yeast DNA polymerase . WRN also helps DNA polymerase  replicate pass 
hairpin and tetraplex structures [Reviewed in Opresko et. al., 2003]. 
The influence of WRN on polymerase  activity has been shown in an experiment. In this 
experiment different amounts of polymerase  was tested with WRN present and in the absence of 
WRN [Kamath-Loeb, 1999]. 
 
The working substrate for polymerase  was a p32 labeled 14-nt primer attached to a 
complementary 46-nt DNA template 
The reactions were carried out in a buffer containg triszHCl buffer (with pH 7.4), MgCl2, 5 DTT,  
BSA respectively dATP, dGTP, dCTP and DTTP. For each specific amounts of polymerase  a 
buffer with WRN (about 6 fmol/10 L reactions) and a buffer without WRN were tested. The 
reaction took place in 37˚ C in 10 minuttes. 
The sizes of the DNA fragments in every test were then investigated by determining size in a gel. 
Higher polymerase  activity will be indicated as longer DNA-fragments (which did not travel 
much in the gel compare to smaller fragments). 
The strand making activity of polymerase , dnTPs and possible WRN can be shown in Figure 12. 
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Figure 12 Strand making activity of polymerase , dnTPs and possible WRN. 
Figure 13 shows the result. 
 
 
Figure 13 Effect of WRN on pol  activity in the present or absence of WRN proteins.  [Kamath-Loeb et. al, 
1999] 
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Lane 
R= 
right 
L=left 
Contains 
1 L DNA substrat. 
1 R DNA and WRN protein 
2 L DNA product of 1.3 fmol/10 L reactions polymerase  and no WRN protein 
2 R DNA product of 1.3 fmol/10 L reactions polymerase  and WRN protein 
3 L DNA product of 0.66 fmol/10 L reactions polymerase  and no WRN protein 
3 R DNA product of 0.66 fmol/10 L reactions polymerase  and WRN protein 
4 L DNA product of 0.33 fmol/10 L reactions polymerase  and  no WRN protein 
4 R DNA product of 0.33 fmol/10 L reactions polymerase  and WRN protein 
5 L DNA product of 0.166 fmol/10 L reactions polymerase  and no WRN protein 
5 R DNA product of 0.166 fmol/10 L reactions polymerase  and WRN protein 
6 L DNA product of 0.083 fmol/10 L reactions polymerase  and no WRN protein 
6 R DNA product of 0.083 fmol/10 L reactions polymerase  and WRN protein 
7 L DNA product of 0.04 fmol/10 L reactions polymerase  and no WRN protein 
7 R DNA product of 0.04 fmol/10 L reactions polymerase  and WRN protein 
 
The experiment clearly shows that the replication activity of DNA polymerase  increase with 
WRN interaction. Even in the case of little or no replication activity (lane 4L, 5L and 6L) addition 
of WRN activates replication (4R, 5R, 6R). When a big amount of  polymerase  is present (lane 2L 
and 2R) WRN does not seems to be important. 
It is worth to mention that the experiment was done using yeast polymerase  but this is still a 
strong indication. 
 
It is also worth noticing that another experiment with DNA polymerase  complex shows that WRN 
does not have an effect on DNA polymerase  activity when PCNA is present [Kamath-Loeb et. al., 
1999]. This indicates, that PCNA have functions both increase the polymerase  activity but that 
respectively PCNA and WRN are used in different situations. (Based on the WRN proteins ability 
to unwind DNA structures WRN may help DNA polymerase  in case stalled replication fork) 
[Kamath-Loeb et. al., 1999]. 
 
• PCNA2 
                                                 
2
 PCNA is a part of the 175S multiprotein DNA replication complex and involved in both DNA replication and repair 
  
	 fffiflffi  !""#$%
  
 21 
PCNA wraps around DNA and recruits other proteins including polymerase . Experiments have 
shown that WRN and PCNA colocalize at replication foci. This suggests a cooperative role for 
these two proteins in cycling primary cells. .The interaction site is the conserved PCNA-binding 
motif and because other proteins use this site as well it has been proposed that protein competition 
can control WRN activities. However, PCNA recruits thousands of proteins and therefore WRN 
attraction to PCNA does not directly indicates a molecular association. [Reviewed in Ozgenc and 
Loeb., 2005]. 
 
An experiment described in the article “The Werner syndomre Gene Product Co-purifies with the 
DNA Replication Complex and Interacts with PCNA and Topoisomerase I” [Lebel et al. 1999] 
shows a direct interaction between PCNA and WRN.  
The co-immunoprecipitation experiment was done. In this experiment about 500 g of the multi 
replication complex were isolated from respectively wild type and WRN deficient ES. Theses 
complexes from each of theses cells were precipated with WRN antibody binding to beads. The 
binding complexes were then separated on a gel and bound proteins were visualized be using the 
same antibody or PCNA-antibody. 
This is shown in Figure 14. 
 
Figure 14 Result of co-immunoprecipitation between WRN proteins and PCNA [Lebel et. al, 1999]. 
 
This indicates that the multi replication complex in the wild type cells contained both WRN and 
PCNA because of a WRN-WRN antibody bond and it indicates a WRN-PCNA bond. Because no 
WRN was present in the multi replication complex from the WRN deficient cells, no complex 
(without WRN) could bind the WRN antibody and no WRN and no PCNA was present. 
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• Topoisomerase I3 
Experiments have shown that Topoisomerases I and WRN interact. WRN helps topoisomerase to 
relax negatively supercoiled DNA. [Reviewed in Ozgenc and Loeb, 2005]. 
In a co-immunoprecipitation experiment performed with all extracts from with human colon 
carcinoma SW480 cell line shows binding between WRN and Topoisomerases I [Lebel et .all, 
1999]. 
Human colon carcinoma SW480 cell lysate was immunoprecipated by WRN antibody and added on 
a gel with the same WRN antibody PCNA antibody or Topisomerase I antibody. 
 
Figure 15 Result of different antibodies on human-WRN antibody immunoprecitation [Lebel et .all, 1999] 
Lane Substrate 
1 & 2 Cell lysate (control lanes) 
3,5 & 7 Immunoprecipates from WRN antibody binding. 
4,6,8 Immunoprecipates from WRN antibody binding + WS peptide 
 
Gel Anti body 
WS-gel WRN antibody 
Topo 1 Topisomerase I antibody 
PCNA PCNA antibody 
 
All 3 antibodies in lanes 3, 5 and 7 clearly indicate that all these 3 replications proteins (WRN, 
PCNA and Topisomerase I ) bind. 
By using a WS peptide it is possible to check if the WRN antibody really binds to WRN (and 
therefore also WS peptide). By using a concentration of WS peptides these peptides would then 
block for WRN binding to WRN antibody. 
 
 
                                                 
3
 The topoisomerases I changes the linking number DNA replication in order to torsional stress that 
is causes by the replication fork moving forward. [Reviewed in Ozgenc and Loeb, 2005] 
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Telomere 
The telomere is localized at both end of a chromosome. The telomere part of the chromosomes 
consists of a sequence of repeating bases-paris. (In humans it is 10 kb to 15 kb of the repeating 
sequence TTAGGG). 
In somatic cells every cell division causes the telomeres to be become shorter and shorter because 
without telomerase the end of the telomere can not be copied. [Griffiths et. al 2008]. 
However, in germ cells the enzyme “telomerase” build the missing part of the telomere and 
therefore these cells do not have an upper limit for cell divisions. 
It is a widespread theory that shortening of the telomeres is one of the processes that takes part of 
during normal aging of an individual [Griffiths et al., 2008].  
 
The reason why telomeres become shorter is that the DNA polymerase working on the lagging 
strand cannot copy that last part of this strand because the last RNA primer used to place the 
Okazaki fragment can not be replaced by DNA. This is because lagging-strand synthesis must have 
primers ahead of the process. Therefore the copy of the lagging strand will be shorter and shorter 
for each replication [Griffiths et al., 2008]. 
 
Unprotected telomere end and telomere structural changes can also causes telomere shortening due 
to double strand breaks [Reviewed in Orren, 2006]. 
 
It is a well-known theory, that when telomeres become too short the cells stop the replication 
process. That is; there is an upper limit with respect to cell divisions [Griffiths, 2008]. As an 
example; an experiment with telomerase-defective mice having shorter telomeres than wild type 
mice, showed that shorter telomeres have an impact on most tissue for instance skin, bone marrow, 
liver, heart and blood vessels. These tissues were also showing less replicative capacity [Canela et 
al., 2007]. 
 
Also a experiment with telomeres from Werner syndomre-fibroblast cells shows that the telomeres 
are more exposed for telomere fragment lost than normal fibroblast cells [Reviewed in Orren, 
2006]. 
Observations have also showed that primary skin fibroblasts cells from Werner syndrome-patients 
stopped dividing after only 15-25 generations compared to 50-80 generations in normal skin 
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fibroblasts cells [Reviewed in Orren, 2006]. This could indicate a link between the Werner 
syndomre premature aging phenotype and WRN role in telomere-maintenance. 
 
But how does the WRN protein interact with the telomere metabolism? 
 
WRN helps unfolding critical DNA structures 
All though the precise function of the WRN-protein is still unknown, there are many indications 
that WRN in fact has a function in respect to telomere replication in the S-phase of the cell cycle. 
In the article “Defective Telomere Lagging Strand Synthesis in Cells Lacking WRN Helicase 
Activity” [Crabbe et. al., 2004] the authors tested a hypothesis saying that WRN plays an important 
role in the replication of telomeres because of the G-rich natures of telomeres. G-rich DNA has 
been suggested to form different structures that make replication difficult; for an instance G-
quadruplexes. Experiments show that the telomere sequence (TTAGGG)n form this structure in 
vitro and human telomeres form this structure on bacterial plasmids [Reviewed in Opresko, 2007]. 
 
Such structures can stop the replication fork and cause strand breaks. The authors hypothesize that 
WRN-protein is helping unfolding such structures allowing the replication process to move on. This 
can be illustrated this way: 
 
 
Figure 16 Possible function of the WRN protein [Gilson and Vincent, 2007] 
The figure shows (top) how a G-quadruplexes forms in the G-rich 
DNA double strand. This structure can course a replication fork 
stall. 
WRN (middle) is able to unfold the structure helping the replication 
to move on (bottom). 
 
The hypothesis is based on experiments made by the authors. Using flourescent in situ hybridization 
(FISH) to mark the telomeres it was possible to check if a whole or big part of each chromosomes 
telomeres had been lost. 
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In the experiments (going on for at least 26 metaphases for each culture) some of the chromatids 
seem to loose their telomere, that is, no FISH-probe indicated a telomere. This “lost-telomere” 
phenotype was termed STL (Sister Telomere Lost). 
All though STL occurred in all the cell culture tested, there was a significant difference in STL 
occurrence in cultures differing only with respect to a viral infection of a wild type WRN and a viral 
infection with the dominant negative WRN, respectively. 
 
In an experiment with HeLa cells expressing WRN wild type or dominant negative WRN 
respectively (K577M), the STL’s were counted. K577M is a WRN gene having a mutation in the 
helicase-domain. 
 
 
Figure 17 Comparison between wild type WRN and K577M domaint negative WRN (the * indicate mutation) [ 
Brosh et. al. , 2001] 
 
In the wild type cultures there were 0.8 STL-events pr cell however in the culture expressing the 
dominant negative WRN gene there were 2.2 STL-events pr. cell. 
The difference in the number of STL’s can been seen in this pictures taken as part of the 
experiment. 
 
Wild type (no STL’s on picture)               Dominant negative WRN (arrows indicate STL’s). 
 
If you look closely at these pictures it is worth noticing that it looks like if a telomere is either 
completely missing or present. That is: There are no partly missing telomeres. In the article 
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“Telomere ResQue and preservation—Roles for the Werner syndrome protein and other RecQ 
helicases” [Opresko, 2007] this issue has been discussed. It was suggested that critical stalls of the 
replication fork are very rare, and therefore WRN protein will only play a role in the few situation 
where such a stall occurs, but a defect WRN will then be fatal. 
Because shorter or missing telomeres may affect the whole cell this could be fatal. That is; 
experiments show that it is the shortest telomere that is critical for cell viability and chromosome 
stability. [Hemann et al., 2001]. 
This is also indicated by experiments where agents that induce replication fork block cause 
hypersensitive reactions in WS cells. It has been observed that telomerase can decrease the number 
of telomere erosions indicating that telomerase can mask the impact of a defect WRN protein 
[Reviewed in Opresko, 2007]. In tumor cells lacking telomerase, WRN protein can be found near 
some parts of the telomeres but in cells having telomerase no WRN protein is allocated at 
telomeres.  [Reviewed in Opresko, 2007]. 
 
WRN co-localize with TRF2 and TRF1 
Experiments has shown that WRN co-localizes with TRF1 and TRF2 (telomeric repeat bindings 
factors) at telomeric DNA in the late S-phase of the cell cycle and that the protein co-
immunprecipitates with TRF2. [Reviewed in Orren, 2006]. 
Both TRF1 and TRF2 are actually involved in shortening telomeres. For instance, experiments have 
shown that these two proteins can cause a replication fork stall at the end of the telomere [Ohki and 
Ishikawa, 2004]. 
But at the same time TRF2, TRF1 and WRN binds to the telomeres in the process of making a loop 
in the end of the telomere [Griffiths et. al., 2008] and by that shows that the telomere is not junk 
DNA, and that it should not be removed. That is: The TRF1 and TRF2 have a protective function 
on the telomeres as well [Stansel et. al., 2001]. This is shown in Figure 18. 
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Figure 18 Protection structure in the end of the telomere [Griffiths et. al., 2008] 
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Discussion 
One of the most interesting things about Werner syndrome, apart from the similarities with normal 
aging, is that the syndrome is caused by mutations in a single gene. The fact that a few mutations 
can accelerate so many aging processes is interesting and also shows that the product of this gene, 
the WRN protein, plays a role in a lot of DNA metabolic processes like the processes described in 
this report. This is clearly indicated by the fact that WRN binds and interacts with many proteins. In 
this report, because of pack of time, I only focused on WRN interaction with proteins in telomere 
maintenance and DNA replication but WRN also plays a role in DNA repair etc. [Reviewed in 
Opresko et. al, 2007] 
  
As mentioned, WRN is a part of the RecQ protein family which is considered as being “Care takers 
of the genome” [Reviewed in Hickson, 2003] and this description seems to fit perfectly with the 
WRN protein. 
It seems like there is no process is totally depended on the WRN to function. Most of the time WS 
do not lose telomeres and replication can go on in WS cells all though the number of replication 
origins is decreased compared to normal cells. But lacking of this protein makes a lot of processes 
more unstable and in the end accelerates the aging process causing the aging phenotype of the 
syndrome. 
One of the main tasks for WRN protein seems to be unwinding complex DNA structures. In making 
this report I have constantly encounter experiments and reviews indicating this role for the WRN 
protein. It can also be the link between DNA replication errors and telomere maintains errors 
because lack of unwinding actions can cause errors in both processes.  
I have also discovered that a lot of science still needs to be done in order to find the specific link 
between a mutated WRN gene and the Werner syndrome phenotype. 
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